Is REmogliflozin an effective Drug in MANaging Type-2 diabetes mellitus: A comparative study – (REDMAN)
Background and Aims: Remogliflozin is a new addition to class of Sodium Glucose Cotransporter-2 (SGLT-2) inhibitors available in India. The drug is introduced and marketed at a lower price range as compared to other gliflozins. Remogliflozin is expected to gain preference over other gliflozins as it...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-07-01
|
| Series: | Diabetes Epidemiology and Management |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666970622000269 |